NeoStem, Inc. , a biopharmaceutical company developing novel cell based therapeutics, announced today that it will host a Key Opinion Leader event webcast on Monday, December 1, 2014 from 4:30 to 5:30 PM EST. The webcast will feature a presentation by Timothy Henry, MD, Director of Cardiology at the Cedars-Sinai Heart Institute, who will discuss the significance of the Phase 2 PreSERVE AMI clinical trial, the results of which were previously announced on November 17th.
http://ift.tt/1y2jerH
http://ift.tt/1y2jerH
No comments:
Post a Comment